JPMorgan Chase Financial Co. LLC Files 424B2 Prospectus Supplement

TL;DR

**JPM Chase Financial Co. just filed a prospectus for new securities, likely debt.**

AI Summary

JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., filed a 424B2 prospectus on March 24, 2026, related to its existing shelf registration statement (File No. 333-270004-01). This filing indicates that JPMorgan Chase Financial Co. LLC is offering new securities, likely debt, under its previously approved registration. For investors, this means the company is raising capital, which could be used for general corporate purposes, potentially impacting future earnings or expansion plans, and diluting the value of existing shares if the offering is equity-based, though this filing is for a prospectus supplement, typically for debt.

Why It Matters

This filing signals JPMorgan Chase Financial Co. LLC is actively raising capital, which could affect its financial leverage and future investment capacity.

Risk Assessment

Risk Level: low — A 424B2 filing is a standard prospectus supplement for an existing shelf registration, indicating a routine capital raise rather than an unexpected event.

Analyst Insight

Investors should monitor subsequent filings (e.g., pricing supplements) to understand the specific terms, size, and use of proceeds for the securities being offered, as this will clarify the impact on the company's financials.

Key Numbers

• 333-270004-01 — Shelf Registration File No. (The registration under which the securities are being offered by JPMorgan Chase Financial Co. LLC)
• 0001665650 — CIK for JPMorgan Chase Financial Co. LLC (Unique identifier for the filing entity)
• 0000019617 — CIK for JPMorgan Chase & Co. (Unique identifier for the parent company)

Key Players & Entities

• JPMorgan Chase Financial Co. LLC (company) — Filer of the 424B2 prospectus supplement
• JPMorgan Chase & Co. (company) — Parent company of the filer
• March 24, 2026 (date) — Filing date of the 424B2
• 333-270004-01 (dollar_amount) — File number for the shelf registration statement

Forward-Looking Statements

• JPMorgan Chase Financial Co. LLC will successfully raise capital through this offering. (JPMorgan Chase Financial Co. LLC) — high confidence, target: 2026-06-30

FAQ

Key Financial Figures

• $1,000 — f the notes. Minimum denominations of $1,000 and integral multiples thereof The no
• $37.50 — t will these selling commissions exceed $37.50 per $1,000 principal amount note. See "
• $920.00 — lue of the notes would be approximately $920.00 per $1,000 principal amount note. The e
• $900.00 — ng supplement and will not be less than $900.00 per $1,000 principal amount note. See "
• $265.00 — ew Date Call Premium Amount First $265.00 Second $331.25 Third $397.50
• $331.25 — ium Amount First $265.00 Second $331.25 Third $397.50 Fourth $463.75
• $397.50 — $265.00 Second $331.25 Third $397.50 Fourth $463.75 Fifth $530.00
• $463.75 — $331.25 Third $397.50 Fourth $463.75 Fifth $530.00 Sixth $596.25 S
• $530.00 — $397.50 Fourth $463.75 Fifth $530.00 Sixth $596.25 Seventh $662.50
• $596.25 — h $463.75 Fifth $530.00 Sixth $596.25 Seventh $662.50 Eighth $728.75
• $662.50 — $530.00 Sixth $596.25 Seventh $662.50 Eighth $728.75 Final $795.00
• $728.75 — $596.25 Seventh $662.50 Eighth $728.75 Final $795.00 Hypothetical Payout
• $795.00 — $662.50 Eighth $728.75 Final $795.00 Hypothetical Payout Examples The fo
• $1,265.00 — automatically called Total Payment $1,265.00 (26.50% return) Because the closing l
• $1,795.00 — automatically called Total Payment $1,795.00 (79.50% return) Because the closing l

Filing Documents

• form424b2.htm (424B2) — 195KB
• image_001.jpg (GRAPHIC) — 21KB
• image_002.jpg (GRAPHIC) — 5KB
• image_006.jpg (GRAPHIC) — 177KB
• image_003.gif (GRAPHIC) — 3KB
• image_004.gif (GRAPHIC) — 5KB
• image_005.gif (GRAPHIC) — 5KB
• 0001918704-26-008021.txt ( ) — 495KB

From the Filing

PRICING SUPPLEMENT The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. March , 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(2) JPMorgan Chase Financial Company LLC Structured Investments Review Notes Linked to the MerQube US Large-Cap Vol Advantage Index due April 2, 2029 Fully and Unconditionally Guaranteed by JPMorgan Chase & Co. The notes are designed for investors who seek early exit prior to maturity at a premium if, on any Review Date, the closing level of the MerQube US Large-Cap Vol Advantage Index, which we refer to as the Index, is at or above the Call Value. The earliest date on which an automatic call may be initiated is March 30, 2027. Investors should be willing to forgo interest and dividend payments and be willing to accept the risk of losing some or all of their principal amount at maturity. The Index is subject to a 6.0% per annum daily deduction. This daily deduction will offset any appreciation of the futures contracts included in the Index, will heighten any depreciation of those futures contracts and will generally be a drag on the performance of the Index. The Index will trail the performance of an identical index without a deduction. See "Selected Risk Considerations — Risks Relating to the Notes Generally — The Level of the Index Will Include a 6.0% per Annum Daily Deduction" in this pricing supplement. The notes are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co. Any payment on the notes is subject to the credit risk of JPMorgan Financial, as issuer of the notes, and the credit risk of JPMorgan Chase & Co., as guarantor of the notes. Minimum denominations of $1,000 and integral multiples thereof The notes are expected to price on or about March 27, 2026 and are expected to settle on or about April 1, 2026. CUSIP: 46660RJF2 Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, "Risk Factors" beginning on page PS-11 of the accompanying product supplement, "Risk Factors" beginning on page US-4 of the accompanying underlying supplement and "Selected Risk Considerations" beginning on page PS-5 of this pricing supplement. Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense. Price to Public (1) Fees and Commissions (2) Proceeds to Issuer Per note $1,000 $ $ Total $ $ $ (1) See "Supplemental Use of Proceeds" in this pricing supplement for information about the components of the price to public of the notes. (2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to other affiliated or unaffiliated dealers. In no event will these selling commissions exceed $37.50 per $1,000 principal amount note. See "Plan of Distribution (Conflicts of Interest)" in the accompanying product supplement. If the notes priced today, the estimated value of the notes would be approximately $920.00 per $1,000 principal amount note. The estimated value of the notes, when the terms of the notes are set, will be provided in the pricing supplement and will not be less than $900.00 per $1,000 principal amount note. See "The Estimated Value of the Notes" in this pricing supplement for additional information. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. Pricing supplement to product supplement no. 4-I dated April 13, 2023, underlying supplement no. 5-III dated March 5, 2025, the prospectus and prospectus supplement, each dated April 13, 2023, and the prospectus addendum dated June 3, 2024 Key Terms Issuer: JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co. Guarantor: JPMorgan Chase & Co. Index: The MerQube US Large-Cap Vol Advantage Index (Bloomberg ticker: MQUSLVA). The level of the Index reflects a deduction of 6.0% per annum that accrues daily. Call Premium Amount: The Call Premium Amount with respect to each Review Date is set forth below: first Review Date: at least 26.500% $1,000 second Review Date: a

View Full Filing

View this 424B2 filing on SEC EDGAR